RxDoctor Payments DataLook up a doctor →

Stephen Grubb, MD

Family Medicine · Little River, SCNPI 1689672784

Payments from drug & device makers

$3,442,965in general payments, 2019–2025

Across 1,326 payments — averaging $2596.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.9M
  • Novartis$505K
  • Eli Lilly$461K
  • Pfizer$291K
  • Ionis Pharmaceuticals, Inc.$199K
  • Janssen Research & Development, LLC$112K
  • plus $21K from 54 others
$234,793in research payments, 2019–2025

Across 5 payments — averaging $46,959 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$235K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)124$1,855,390
Novartis38$504,863
Eli Lilly5$460,587
Pfizer112$290,663
Ionis Pharmaceuticals, Inc.8$199,203
Janssen Research & Development, LLC23$111,553
GSK142$5,252
AstraZeneca98$2,025
AbbVie(2 entities)165$1,876
Boehringer Ingelheim49$1,848
Novo Nordisk88$1,443
Astellas Pharma US Inc60$1,172
Lilly USA, LLC90$1,073
Johnson & Johnson57$953
Amarin Pharma, Inc.36$533
Merck27$465
Radius Health, Inc.16$375
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$364
Takeda Pharmaceuticals U.S.A., Inc.15$218
Antares Pharma, Inc.11$185
Sumitomo Pharma America, Inc.7$174
Avanir Pharmaceuticals, Inc.3$153
Sanofi-aventis U.S. LLC9$146
Abbott8$146
Dexcom, Inc.3$146
Teva Pharmaceuticals USA, Inc.4$141
Sunovion Pharmaceuticals Inc.7$137
Forte Bio-pharma LLC6$133
Mylan Specialty L.p.8$126
E.r. Squibb & Sons, L.L.C.9$123
Inari Medical, Inc.1$119
Otsuka America Pharmaceutical, Inc.5$104
Daiichi Sankyo Inc.6$99
Esperion Therapeutics, Inc.7$97
Nestle Healthcare Nutrition Inc.4$83
Bayer6$83
Insulet Corporation3$81
Nevro Corp.4$80
Corium, LLC4$80
Medtronic1$76
Exact Sciences5$74
Xeris Pharmaceuticals, Inc.3$69
Ardelyx, Inc.3$48
Biogen3$46
Corcept Therapeutics2$38
Eisai Inc.3$36
Aytu Biopharma, Inc.1$28
Arbor Pharmaceuticals, Inc.2$25
Viatris Specialty LLC1$24
Zimmer Biomet1$24
Acerus Pharmaceuticals Corporation1$18
Ultragenyx Pharmaceutical Inc.1$17
Insmed, Inc.1$16
Clarus Therapeutics Inc.1$16
Avion Pharmaceuticals1$16
Virtus Pharmaceuticals LLC1$15
Irhythm Technologies, Inc.1$15
Tandem Diabetes Care, Inc.1$14
Shire North American Group Inc1$14
Boston Scientific1$13

How this compares

$3,442,965 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$963,115
Medicare patients
482
Services billed
14,695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Little River

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →